Dr. Sae Ishimaru presents an overview of the study design from the first sub-trial under the LLS Pediatric Acute Leukemia (PedAL) Master Clinical Trial. PedAL is a key part of The Dare to Dream Project, focused on transforming treatment & care for kids with blood cancer. #ASH22
Follow
The Leukemia & Lymphoma Society
@LLSusa
The Leukemia & Lymphoma Society’s Tweets
Four new abstracts on the Beat AML® Master Clinical Trial are being presented at #ASH22 by:
🔬Antonia Bennett
🔬Uma Borate
🔬Joshua Zeidner
🔬Eytan Stein of
6 years in, this trial continues to generate strong results💪
5
17
“Approximately 10% of patients with hematologic malignancy who had 2-4 COVID vaccines reported a breakthrough infection during the Omicron surge,” Sneha Reddy presents data from the LLS National Patient Registry at #ASH22. COVID vaccine info for patients👉 bit.ly/3FDhihi
1
4
13
Quote Tweet
Best @ASH_hematology picture with my friends from the blood stream! #Leukocyte #Erythrocyte #Platelet! All in the house #ASH22 @doctorpemm @DavidSteensma @UTHealthSAMDA
2
19
📢 It's day two at #ASH22! Don't miss out on these afternoon sessions all about new, emerging treatment approaches. 🚨
Quote Tweet
ASH continually aims to drive advancement & innovation in the field of #hematology. Check out this thread of #ASH22 sessions on new, emerging treatment approaches you don’t want to miss today
Show this thread
9
📢At the #ASH22 Patient Advocacy Forum, (second from left) shared: “LLS has a long history of work in #HealthEquity, and we are committed to reaching more patients in underserved communities so that they can access the treatment & support they need.”
1
6
#ASH22 Update! 🚨📣, President and CEO of The Leukemia & Lymphoma Society, joins the panel to discuss health equity and best practices for hematology patients.
1
14
Update from #ASH22! 🚨 Our collaborative symposium with , “Elevating Equity in Caring for Patients with Hematologic Malignancies” is live now where experts are discussing how to address barriers to #HealthEquity. Join us 👉 bit.ly/3VMjyIL
8
Our LLS staff in New Orleans is looking forward to participating in some of the afternoon workshops! #ASH22
Quote Tweet
The #ASH22 Scientific Workshops are happening today from 2:00-5:00 p.m. CT! Check out the discussion topics
Show this thread
4
Quote Tweet
Learn & Earn #CME this Friday at ASH 2022 as experts discuss how to implement strategies & identify resources that proactively address barriers associated with disparities in care & #health outcomes. #OncTwitter
In partnership with @LLSusa.
Register: ms.spr.ly/6013eyMTN
4
Thank you to all attendees and panelists at today’s LLS #ASH22 Satellite Symposium. 🙌 Our world-renowned panel provided real hope for patients by sharing state of the art science and the promising future for groundbreaking blood cancer treatments.
1
17
Happening now at our #ASH22 Satellite Symposium: of shares how cell-free DNA has the potential to guide new therapies for blood cancer!
1
3
25
One of the visionary leaders of our PedAL Master Clinical Trial, Dr. Soheil Meshinchi of , shares the latest in targeted treatment development for pediatric acute leukemia at our #ASH22 Satellite Symposium.
5
26
At our #ASH22 Satellite Symposium, Dr. Katherine Donovan of provides insight into an up & coming type of blood cancer treatment: targeted protein degradation, which could change treatment as we know it!
1
1
35
Show this thread
Dr. Helen Heslop of , a world-renowned expert in immunotherapy, takes the stage at our #ASH22 Satellite Symposium to share what’s next in CAR T-cell immunotherapy, including: new targets, improved access, making treatments even better and longer lasting.
1
14
“LLS has invested more than $1.5B in blood cancer research since its inception, supporting remarkable scientists whose work has led to breakthrough advances.” Lee Greenberger, Chief Scientific Officer, shares opening remarks from our #ASH22 Satellite Symposium! 🎤
10
32
Happening now! 📣 During our #ASH22 Satellite Symposium, “Navigating the Frontier of Hematological Malignancy Therapies”, experts discuss what’s next in blood cancer science. Speakers include representatives from , , & .
4
24
We're thrilled to take part in the 64th annual ASH meeting! Join us this weekend for highlights of new research in blood cancer treatment & progress in equitable access to care! We proudly support our LLS-funded researchers & TAP partners presenting at #ASH22.
3
14
We remember those we have deeply loved and lost. With the holidays approaching, may their light live on in our hearts always. ❤️ Who is in your heart today? For support, call on us today 👉 bit.ly/3XYjqaP
4
16
GAME ON 🎮 Thank you for supporting our mission this year, ! Because of supporters like you, we are one step closer to creating a world without blood cancer. Let's do this on Dec. 13 with ! #CancelBloodCancer ❤️
Quote Tweet
My next big announcement… let’s fight cancer and let’s cut my hair
tiltify.com/@jakelucky/fee
Show this thread
1:50
259.7K views
6
14
Join us as we speak to Dr. Lee Greenberger, the SVP & Chief Scientific Officer of LLS. Dr. Greenberger shares updates on the COVID-19 pandemic, including updated & accurate information to stay safe as we all move into the winter season. Listen now 👉 bit.ly/3EX8DEU
0:07
139 views
1
3
(9/9) NFT donations are a great way to help #CancelBloodCancer - donate #crypto today 👉 bit.ly/3P47cJr #NFTTuesday
1
9
Show this thread
(8/9) Today is #NFTTuesday, the only day solely dedicated to NFT philanthropy and NFT fundraisers like Daniel ❤️ Over the past year, the NFT community has donated millions of dollars in crypto to charitable organizations like LLS.
1
8
Show this thread
(7/9) Daniel’s goal is to raise over 70 Ethereum (over $100K USD) for LLS from the primary sale alone, donating 40% of each Lil Sicky purchase, along with 60% of royalties generated from secondary sales, via .
1
1
9
Show this thread
(6/9) “It started as doodles to pass time & try to stay positive,” Daniel said. “Then we thought, maybe we can actually do some good with this. Not only do I look at Lil Sicky as a digital expression of my journey, but hope it can support others going through similar challenges.”
1
1
9
Show this thread
(5/9) With the help of some web3 friends and a computer algorithm, 5,000 Lil Sickys were then generated! Each Lil Sicky has a random and unique combination of traits, available for purchase on the Ethereum blockchain.
1
8
Show this thread
(4/9) With that, “Lil Sicky” was born ― a character inspired by Daniel’s favorite activities, dreams, and childhood memories. Every trait was hand-drawn on an iPad during his chemotherapy treatments and recovery periods.
1
1
8
Show this thread
(3/9) “Art has been a great stress reliever for me. Since my diagnosis, I've been able to slow down and get back to something I love while going through this challenging time.” - Daniel
1
2
9
Show this thread
(2/9) In November 2021, Daniel was diagnosed with stage three nodular sclerosing Hodgkin #lymphoma. Like so many others during the COVID-19 pandemic, he has been isolated to protect his health and has been unable to work.
1
1
8
Show this thread
(1/9) Meet artist & LLS supporter Daniel, a 27-year-old lymphoma patient who combined his medical diagnosis and love of digital art into an NFT project supporting LLS patients and their families. ❤️ #NFTTuesday
7
18
74
Show this thread
#NFTuesday is the only day solely dedicated to NFT philanthropy! NFT donations are an incredible way to help #CancelBloodCancer––donate #crypto today 👉 bit.ly/3itmbka
0:09
267 views
9
27
Thank you for the love, ! Let's #CancelBloodCancer and continue spreading awareness as well as the need for action! 🏈❤️
Quote Tweet
Official
Despite being out for the season, @Darnell_M1 still plans to honor his father this week with cleats supporting @LLSusa
#MyCauseMyCleats
1
10
What is a clinical trial❓Should you consider one❓We teamed up with the to bust top myths about clinical trials. Check it out 👉 bit.ly/3VHKutv
4
9
📣 GREAT NEWS 📣 The granted approval yesterday to olutasidenib for the treatment of adults with acute myeloid leukemia (AML) with a susceptible IDH1 mutation that has returned or worsened despite earlier treatments. Read more 👉 bit.ly/3VqKDkQ
10
34
Quote Tweet
Official
Reppin' a few of our favorite causes this week 
#MyCauseMyCleats
#MyCauseMyCleats
0:25
12.8K views
1
6
Did you know many companies offer a matching gift program? When you make a donation to LLS, your company can double or even triple the value of your gift! Use our company finder to see if your company matches today 👉 bit.ly/3B1RBVa
2
5
While blood cancer doesn't discriminate, health inequalities affect many communities at different rates. We are investing in breaking down healthcare barriers. Learn more 👉 bit.ly/3gFV9Wf #NativeAmericanHeritageMonth
2
Show this thread